FindTrial
Sign In

To study the action of Dexmedetomidine drug added to Ropivacaine for blocking nerves before below knee surgery

EVALUATION OF THE EFFECT OF DEXMEDETOMIDINE AS ADJUVANT TO ROPIVACAINE IN ULTRASOUND GUIDED POPLITEAL SCIATIC NERVE BLOCK IN BELOW KNEE SURGERY-A ONE YEAR HOSPITAL BASED DOUBLE BLIND RANDOMIZED CLINICAL TRIALâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050377
Enrollment
60
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Popliteal Sciatic nerve block: Popliteal Sciatic nerve block is being increasingly used for below knee surgeries.Post operative analgesia produced by commonly used local anaesthetics su

Sponsors

Hridya VN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA grade I,II and III 2.Age between 18-70years undergoing Below knee surgry

Exclusion criteria

Exclusion criteria: 1)Patient refusal. 2)ASA grade IV or more 3)History of any Allergy to study drug. 4)Any contraindication for regional anaesthesia 5)Infection at intended site of injection 6)Pregnant patients

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Dexmedetomidine as adjuvant to Ropivacine in ultrasound guided Popliteal Sciatic nerve block in below knee surgery.Timepoint: 1st 24 hours post surgery—

Secondary

MeasureTime frame
To determine the effect on intraoperative hemodynamic parameters. To determine the time to 1st dose of analgesic in the postoperative period. To determine the total analgesic requirement in 1st 24 hours post surgery Timepoint: 1st 24 hours post surgery—

Countries

India

Contacts

Public ContactHridya VN

Jawaharlal Nehru Medical college,Belagavi

vandanagogate@gmail.com9019693125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026